UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nivolumab Exposure-Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non-Small Cell Lung Cancer

Clinical cancer research, 2017-09, Vol.23 (18), p.5394-5405

2017

Volltextzugriff (PDF)

Zwitterionic Chitosan Derivatives for pH-Sensitive Stealth Coating

Biomacromolecules, 2010-09, Vol.11 (9), p.2352-2358

2010

Volltextzugriff (PDF)

Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release

PloS one, 2012-01, Vol.7 (1), p.e30899

2012

Volltextzugriff (PDF)

1280 Modeling of direct (EGFR- based) and ADCC cytotoxic effect of Cetuximab on the basis of literature available in vitro data

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1420-A1420

2023

Volltextzugriff (PDF)

Erratum to “Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors” [Journal of Controlled Release 158 (2012) 386–392]

Journal of controlled release, 2012-08, Vol.162 (1), p.257-257

2012

Volltextzugriff (PDF)

Delayed cutaneous wound healing and aberrant expression of hair follicle stem cell markers in mice selectively lacking Ctip2 in epidermis

PloS one, 2012-02, Vol.7 (2), p.e29999

2012

Volltextzugriff (PDF)

874 A quantitative systems pharmacology model of head and neck squamous cell carcinoma: a tool for evaluating treatment outcomes for combination therapies

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A975-A975

2023

Volltextzugriff (PDF)

Drug Delivery Systems for Intraperitoneal Therapy

Pharmaceutical research, 2010-05, Vol.27 (5), p.735-738

2010

Volltextzugriff (PDF)

The long-term impact of maternal diabetes on neonatal health and lifelong well being

International Journal Of Community Medicine And Public Health, 2024-09, Vol.11 (10), p.4140-4143

2024

Volltextzugriff (PDF)

Nanotechnology based drug delivery in cancer treatment: enabling controlled and targeted release of medications

International journal of research in medical sciences, 2024-08, Vol.12 (9), p.3522-3527

2024

Volltextzugriff (PDF)

Effect of obesity in pregnancy: implications for maternal and fetal health

International journal of reproduction, contraception, obstetrics and gynecology, 2024-08, Vol.13 (8), p.2215-2219

2024

Volltextzugriff (PDF)

493 First-in-human phase 1/2 trial to evaluate the safety and initial clinical activity of DuoBody®-CD40×4–1BB (GEN1042) in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A525-A525

2021

Volltextzugriff (PDF)

786 Dose selection for DuoBody®-PD-L1×4-1BB (GEN1046) using a semimechanistic pharmacokinetics/pharmacodynamics model that leverages preclinical and clinical data

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A821-A821

2021

Volltextzugriff (PDF)

Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncology

British journal of clinical pharmacology, 2019-09, Vol.85 (9), p.2045-2058

2019

Volltextzugriff (PDF)

Nivolumab Clearance Is Stationary in Patients With Resected Melanoma on Adjuvant Therapy: Implications of Disease Status on Time‐Varying Clearance

Clinical pharmacology and therapeutics, 2019-11, Vol.106 (5), p.1018-1027

2019

Volltextzugriff (PDF)

ID: 335318 Real World Outcome Data for Spinal Cord Stimulation – Ethnic Minorities and Social Deprivation

Neuromodulation (Malden, Mass.), 2024-10, Vol.27 (7), p.S276-S276

2024

Volltextzugriff (PDF)

Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma

Journal of clinical pharmacology, 2017-12, Vol.57 (12), p.1527-1533

2017

Volltextzugriff (PDF)

O013 / #264 REAL WORLD OUTCOME DATA FOR SPINAL CORD STIMULATION FOR LANGUAGE BARRIER IN ETHNIC MINORITY- FIRST PROSPECTIVE STUDY

Neuromodulation (Malden, Mass.), 2023-12, Vol.26 (8), p.S91

2023

Volltextzugriff (PDF)

N-Methyl-D-aspartate Receptor Subunits Are Non-myosin Targets of Myosin Regulatory Light Chain

The Journal of biological chemistry, 2009-01, Vol.284 (2), p.1252-1266

2009

Volltextzugriff (PDF)

Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant

Current HIV research, 2014-01, Vol.12 (2), p.121-131

2014

Volltextzugriff (PDF)

Prematurity and associated future paediatric airway pathology: experience from a single tertiary paediatric ENT centre

European archives of oto-rhino-laryngology, 2020-11, Vol.277 (11), p.3179-3184

2020

Volltextzugriff (PDF)

Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors

Journal of controlled release, 2012-03, Vol.158 (3), p.386-392

2012

Volltextzugriff (PDF)

ID: 344162 A Prospective Single Centre Study Investigating 1KHz/FAST/Microburst Neurostimulation's Effects on PSPS Type-1 Over 24 Months

Neuromodulation (Malden, Mass.), 2024-10, Vol.27 (7), p.S125-S125

2024

Volltextzugriff (PDF)

ID: 335557 Pre-Emptive Use of Lidocaine-Patches Following SCS-Implant to Prevent Postoperative-Pain And Hypersensitivity: 6 Month Prospective Data

Neuromodulation (Malden, Mass.), 2024-10, Vol.27 (7), p.S84-S84

2024

Volltextzugriff (PDF)

The changing face of paediatric airway endoscopic surgery: An 8-year single surgeon review

International journal of pediatric otorhinolaryngology, 2022-05, Vol.156, p.111104-111104, Article 111104

2022

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(114)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Nivolumab Exposure-Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non-Small Cell Lung Cancer

Zwitterionic Chitosan Derivatives for pH-Sensitive Stealth Coating

Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release

1280 Modeling of direct (EGFR- based) and ADCC cytotoxic effect of Cetuximab on the basis of literature available in vitro data

Erratum to “Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors” [Journal of Controlled Release 158 (2012) 386–392]

Delayed cutaneous wound healing and aberrant expression of hair follicle stem cell markers in mice selectively lacking Ctip2 in epidermis

874 A quantitative systems pharmacology model of head and neck squamous cell carcinoma: a tool for evaluating treatment outcomes for combination therapies

Drug Delivery Systems for Intraperitoneal Therapy

The long-term impact of maternal diabetes on neonatal health and lifelong well being

Nanotechnology based drug delivery in cancer treatment: enabling controlled and targeted release of medications

Effect of obesity in pregnancy: implications for maternal and fetal health

493 First-in-human phase 1/2 trial to evaluate the safety and initial clinical activity of DuoBody®-CD40×4–1BB (GEN1042) in patients with advanced solid tumors

786 Dose selection for DuoBody®-PD-L1×4-1BB (GEN1046) using a semimechanistic pharmacokinetics/pharmacodynamics model that leverages preclinical and clinical data

Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncology

Nivolumab Clearance Is Stationary in Patients With Resected Melanoma on Adjuvant Therapy: Implications of Disease Status on Time‐Varying Clearance

ID: 335318 Real World Outcome Data for Spinal Cord Stimulation – Ethnic Minorities and Social Deprivation

Exposure–Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma

O013 / #264 REAL WORLD OUTCOME DATA FOR SPINAL CORD STIMULATION FOR LANGUAGE BARRIER IN ETHNIC MINORITY- FIRST PROSPECTIVE STUDY

N-Methyl-D-aspartate Receptor Subunits Are Non-myosin Targets of Myosin Regulatory Light Chain

Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant

Prematurity and associated future paediatric airway pathology: experience from a single tertiary paediatric ENT centre

Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors

ID: 344162 A Prospective Single Centre Study Investigating 1KHz/FAST/Microburst Neurostimulation's Effects on PSPS Type-1 Over 24 Months

ID: 335557 Pre-Emptive Use of Lidocaine-Patches Following SCS-Implant to Prevent Postoperative-Pain And Hypersensitivity: 6 Month Prospective Data

The changing face of paediatric airway endoscopic surgery: An 8-year single surgeon review

Suchergebnisse filtern